Amaç & Hipotez:Objectives: The knowledge of the possible differences in the clinical course of COVID-19 infection in cancer patients receiving treatment has not been sufficient to conclude.
📊
Temel Bulgular & Veri:In this study, we retrospectively evaluated lymphocyte counts, LDH levels, neutrophil/lymphocyte ratios (NLR), platelet lymphocyte ratios (PLR), CRP albumin ratios (CRP/Alb), LDH/ albumin ratios in COVID-19 infected cancer patients actively treated in our clinic.
💡
Sonuç & Katkı:Stage of cancer (p=0.028), lymphopenia (p
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri
Abstract
Objectives: The knowledge of the possible differences in the clinical course of COVID-19 infection in cancer patients receiving treatment has not been sufficient to conclude. In this study, we retrospectively evaluated lymphocyte counts, LDH levels, neutrophil/lymphocyte ratios (NLR), platelet lymphocyte ratios (PLR), CRP albumin ratios (CRP/Alb), LDH/ albumin ratios in COVID-19 infected cancer patients actively treated in our clinic. Methods: Cancer patients who were currently under treatment in Department of Medical Oncology, Faculty of Medicine, Pamukkale University during the period between September 2020 and April 2021 were included in the study. During the period, 1363 stage 3-4 patients were received parenteral treatment and 60 patients were diagnosed with COVID-19 infection. Results: The median age of the patients was 60 years (range 19-82 years). Stage of cancer (p=0.028), lymphopenia (p
🔖
Bu Makaleye Atıf Yap
Yaren, A., Ergin, A., Karan, C., Demiray, A. G., Demirel, B. C., Taskoylu, B. Y., Sari, T., Degirmencioglu, S., Dogu, G. G., Avci, E., Dogan, T., Ozdemir, M. (2022). Evaluation of Clinical, Laboratory and Treatment Findings of Oncology Patients Diagnosed with COVID-19 Infection. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 4, 417–421. https://ajindex.com/articles/508618
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemi- ological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020;395:507−13
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer pa- tients in SARSCoV-2 infection: A nationwide analysis in China. Lancet Oncol 2020;21:335−7
Lewis MA. Between scylla and charybdis - oncologic decision making in the time of Covid-19. N Engl J Med 2020;382:2285−7
Zimmer AJ, Freifeld AG. Optimal management neutropenic fever in patients with cancer. J Oncol Pract 2019;15:19−24
Patel R, Park J, Shah A, Saif MW. COVID-19 and cancer patients. Cancer Med J 2020;3:40−8
Novello S, Camps C, Grossi F, Mazieres J, Abrey L, Vernejoux JM, et al. Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases. J Thorac On- col 2011;6:1260−6
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: A multi- center study during the COVID-19 outbreak. Cancer Discov 2020;10:783−91
Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 pa- tients. Blood 2020;136:2881−92
Berghoff AS, Gansterer M, Bathke AC, Trutschnig W, Hunger- länder P, Berger JM, et al. SARS-CoV-2 testing in patients with cancer treated at a tertiary care hospital during the COVID-19 pandemic. J Clin Oncol 2020;38:3547−54
Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol 2020;6:1108−10
Bertuzzi AF, Marrari A, Gennaro N, Cariboni U, Ciccarelli M, Giordano L, et al. Low incidence of SARS-CoV-2 in patients with solid tumours on active treatment: An observational study at a tertiary cancer centre in Lombardy, Italy. Cancers (Basel) 2020;12:2352
Zhang HY, Wang LW, Chen YY, Shen X, Wang Q, Yan Y, et al. A multicentre study of 2019 novel coronavirus disease 2019 outcomes of cancer patients in Wuhan, China. MedRxiv 2020;21:20037127
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020;395:1054−62
Patel R, Park J, Shah A, Saif MW. COVID-19 and cancer patients. Cancer Med J 2020;3:40−8